Ă—
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
FDA Extends Review Period for Applied Therapeutics’ Govorestat by Three Months
BioSpace
FDA Extends Review Period for Applied Therapeutics' Govorestat by Three Months ... Applied Therapeutics on Thursday announced that the FDA is...
1 month ago
US FDA extends review of Applied Therapeutics' genetic disease drug
Reuters
The U.S. Food and Drug Administration has extended its review of Applied Therapeutics' experimental drug to treat galactosemia,...
1 month ago
A deep dive into Applied Therapeutics' data, and questions on Cassava's erased data
STAT
This week a deep dive into the bull and bear sides of the Applied Therapeutics debate, and another well-deserved swipe at Cassava Sciences.
2 months ago
Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference
Yahoo Finance
NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing...
2 weeks ago
Applied Therapeutics Names New Chief Commercial Officer
Contract Pharma
Dale Hooks joins Applied with over 30 years of biopharmaceutical experience in rare disease marketing and sales. Applied Therapeutics Names...
1 month ago
Applied Therapeutics Shares Slip 13% After FDA Extends Drug Review
Morningstar
Applied Therapeutics Shares Slip 13% After FDA Extends Drug Review ... Shares of Applied Therapeutics sank after regulators extended the company's...
1 month ago
FDA extends review period for Applied Therapeutics' NDA
Pharmaceutical Technology
FDA extends review period for Applied Therapeutics' govorestat NDA. A decision on the approval for the asset under the PDUFA is now expected by...
1 month ago
Applied Therapeutics Reports First Quarter 2024 Financial Results
GlobeNewswire
Govorestat NDA for Classic Galactosemia under Priority Review, PDUFA target action date of November 28, 2024 Govorestat MAA under review by...
2 weeks ago
Applied Therapeutics, Inc. (NASDAQ:APLT) Short Interest Update
Defense World
Read Applied Therapeutics, Inc. (NASDAQ:APLT) Short Interest Update at Defense World.
6 days ago
Applied Tx's pediatric rare disease prosect hits another snag
Fierce Biotech
Even after a failed phase 3 pediatric clinical trial, Applied Therapeutics forged ahead with an FDA filing for potential market approval.
1 month ago